Track LGND and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
LGND - Ligand Pharmaceuticals Incorporated (LGND) has a earnings per share of -$0.67, down 150.4% over the past year.
Latest EPS (Actual)
-$0.67
Beat Rate
87.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | $0.98 | -$0.67 | Miss | -168.37% |
| Feb 2026 | $0.63 | $2.12 | Beat | +236.51% |
| Nov 2025 | $1.93 | $3.09 | Beat | +60.10% |
| Aug 2025 | $0.21 | $0.24 | Beat | +14.29% |
| May 2025 | $1.21 | $1.33 | Beat | +9.92% |
| Feb 2025 | $1.19 | $1.27 | Beat | +6.71% |
| Nov 2024 | $1.35 | $1.84 | Beat | +36.30% |
| Aug 2024 | $1.06 | $1.40 | Beat | +32.08% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.